These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 444278)

  • 1. Selective storage of p-hydroxy-d-amphetamine in the dopaminergic nerve terminals.
    Jori A; Caccia S; Guiso A; Ballabio M; Garattini S
    Biochem Pharmacol; 1979 Apr; 28(7):1205-7. PubMed ID: 444278
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution and localization of p-hydroxy-d-amphetamine in rat brain.
    Jori A; Caccia S; Guiso G; Garattini S
    Eur J Pharmacol; 1978 Dec; 52(3-4):361-5. PubMed ID: 729645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of 4-hydroxyamphetamine by rat striatal homogenates.
    Cho AK; Schaffer JC; Fischer JF
    Biochem Pharmacol; 1975 Aug; 24(16):1540-2. PubMed ID: 1191311
    [No Abstract]   [Full Text] [Related]  

  • 4. The accumulation of p-hydroxyamphetamine by brain homogenates and its role in the release of catecholamines.
    Cho AK; Fischer JF; Schaeffer JC
    Biochem Pharmacol; 1977 Aug; 26(15):1367-72. PubMed ID: 901551
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible storage of (+)-amphetamine in catecholaminergic terminals of the striatum and brainstem.
    Jori A; Caccia S; Garattini S
    Eur J Pharmacol; 1977 Feb; 41(3):275-9. PubMed ID: 837972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of the metabolite p-hydroxyamphetamine to the central actions of p-methoxyamphetamine.
    Kaminskas LM; Irvine RJ; Callaghan PD; White JM; Kirkbride P
    Psychopharmacology (Berl); 2002 Mar; 160(2):155-60. PubMed ID: 11875633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of acute and chronic injections of d-amphetamine sulfate and substantia nigra lesions on the distribution of amphetamine and para-hydroxyamphetamine in the rat brain.
    Danielson TJ; Petrali EH; Wishart TB
    Life Sci; 1976 Oct; 19(8):1265-9. PubMed ID: 994725
    [No Abstract]   [Full Text] [Related]  

  • 8. Release of 3H-alpha-methyl-m-tyramine from rat striatum in vitro.
    Dorris RL
    Eur J Pharmacol; 1976 Jan; 35(1):225-8. PubMed ID: 1253825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model.
    Fischer JF; Cho AK
    J Pharmacol Exp Ther; 1979 Feb; 208(2):203-9. PubMed ID: 762652
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative subcellular localization of para-hydroxylated derivatives of ephedrine and amphetamine in rat brain].
    El Guedri H; Rapin J; Jacquot C; Cohen Y
    C R Acad Hebd Seances Acad Sci D; 1975 Sep; 281(9):587-9. PubMed ID: 813909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic-dopaminergic interaction in the striatum: the effect of 6-hydroxydopamine or pimozide treatment on the increased striatal acetylcholine levels induced by apomorphine, piribedil and d-amphetamine.
    Ladinsky H; Consolo S; Bianchi S; Samanin R; Ghezzi D
    Brain Res; 1975 Feb; 84(2):221-6. PubMed ID: 1111831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a specific uptake of dopamine by dopaminergic terminals of the rat cerebral cortex.
    Tassin JP; Thierry AM; Blanc G; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(3):239-44. PubMed ID: 4277015
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution and occurrence of amphetamine and p-hydroxyamphetamine in tissues of the rat after injection of d-amphetamine sulfate.
    Danielson TJ; Boulton AA
    Eur J Pharmacol; 1976 Jun; 37(2):257-64. PubMed ID: 954809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of biogenic amines from isolated nerve endings.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective (+)-amphetamine neurotoxicity on striatal dopamine nerve terminals in the mouse.
    Jonsson G; Nwanze E
    Br J Pharmacol; 1982 Oct; 77(2):335-45. PubMed ID: 7139192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals.
    Ricaurte G; Bryan G; Strauss L; Seiden L; Schuster C
    Science; 1985 Sep; 229(4717):986-8. PubMed ID: 4023719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics and metabolism of amphetamine in the brain of rats of different ages.
    Honecker H; Coper H
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 291(2):111-21. PubMed ID: 1202363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic nerve endings visualised by high-resolution autoradiography in adult rat neostriatum.
    Descarries L; Bosler O; Berthelet F; Des Rosiers MH
    Nature; 1980 Apr; 284(5757):620-2. PubMed ID: 7366732
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of blocking catecholamine uptake on amphetamine-induced circling behaviour in mice with unilateral destruction of striatal dopaminergic nerve terminals.
    Pycock C; Milson JA; Tarsy D; Marsden CD
    J Pharm Pharmacol; 1976 Jun; 28(6):530-2. PubMed ID: 7659
    [No Abstract]   [Full Text] [Related]  

  • 20. Properties of dopamine efflux from rat striatal tissue caused by amphetamine and p-hydroxyamphetamine.
    Fischer JF; Cho AK
    Proc West Pharmacol Soc; 1976; 19():179-82. PubMed ID: 995984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.